EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 51 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,564,361 | +1.9% | 352,907 | 0.0% | 0.06% | +40.9% |
| Q3 2022 | $3,497,000 | +1.2% | 352,907 | 0.0% | 0.04% | +18.9% |
| Q2 2022 | $3,455,000 | -2.2% | 352,907 | -2.7% | 0.04% | +37.0% |
| Q1 2022 | $3,532,000 | +82.2% | 362,618 | +81.3% | 0.03% | +68.8% |
| Q4 2021 | $1,938,000 | +0.2% | 199,998 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $1,934,000 | -0.7% | 199,998 | 0.0% | 0.02% | +14.3% |
| Q2 2021 | $1,948,000 | – | 199,998 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Arena Capital Advisors, LLC- CA | 300,899 | $2,928,000 | 0.23% |
| Exos Asset Management LLC | 45,300 | $438,000 | 0.23% |
| Athanor Capital, LP | 147,800 | $1,429,000 | 0.19% |
| MMCAP International Inc. SPC | 250,000 | $2,418,000 | 0.17% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 65,689 | $637,000 | 0.08% |
| Atalaya Capital Management LP | 40,000 | $387,000 | 0.06% |
| Radcliffe Capital Management, L.P. | 200,000 | $1,946,000 | 0.06% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 300,000 | $2,901,000 | 0.05% |
| FIR TREE CAPITAL MANAGEMENT LP | 150,000 | $1,451,000 | 0.05% |
| Ghisallo Capital Management LLC | 125,000 | $1,214,000 | 0.05% |